186 related articles for article (PubMed ID: 2196811)
1. Contraceptive hormone use and cardiovascular disease.
Shufelt CL; Bairey Merz CN
J Am Coll Cardiol; 2009 Jan; 53(3):221-31. PubMed ID: 19147038
[TBL] [Abstract][Full Text] [Related]
2. Hormonal contraception--what kind, when, and for whom?
Wiegratz I; Thaler CJ
Dtsch Arztebl Int; 2011 Jul; 108(28-29):495-505; quiz 506. PubMed ID: 21814535
[TBL] [Abstract][Full Text] [Related]
3. Hormones and thrombosis: the dark side of the moon.
Barcellona D; Grandone E; Marongiu F
Blood Transfus; 2024 Jan; 22(1):46-54. PubMed ID: 37235737
[TBL] [Abstract][Full Text] [Related]
4. High-fat diet promotes coagulation and endothelial activation in Sprague Dawley rats: Short-term effects of combined oral contraceptives.
Fabunmi OA; Dludla PV; Nkambule BB
Clin Investig Arterioscler; 2024; 36(2):60-70. PubMed ID: 37949735
[TBL] [Abstract][Full Text] [Related]
5. Thrombin generation in a woman with heterozygous factor V Leiden and combined oral contraceptives: A case report.
Zermatten MG; Bertaggia Calderara D; Aliotta A; Alberio L
Res Pract Thromb Haemost; 2020 Mar; 4(3):429-432. PubMed ID: 32211577
[TBL] [Abstract][Full Text] [Related]
6. Longitudinal profile of estrogen-related thrombotic biomarkers after cessation of combined hormonal contraceptives.
Hugon-Rodin J; Fontana P; Poncet A; Streuli I; Casini A; Blondon M
Blood; 2024 Jan; 143(1):70-78. PubMed ID: 37939264
[TBL] [Abstract][Full Text] [Related]
7. Progesterone-Only Contraceptive-Induced Ischemic Colitis.
Rajamanuri M; Garg M; Siddiqui H; Pannala S
ACG Case Rep J; 2024 Apr; 11(4):e01313. PubMed ID: 38566974
[TBL] [Abstract][Full Text] [Related]
8. A Perspective on Hormonal Contraception Usage in Central Nervous System Injury.
Pradhyumnan H; Perez GG; Patel SH; Blaya MO; Bramlett HM; Raval AP
J Neurotrauma; 2024 Mar; 41(5-6):541-551. PubMed ID: 37975282
[TBL] [Abstract][Full Text] [Related]
9. Clot or Not? Reviewing the Reciprocal Regulation Between Lipids and Blood Clotting.
Zhang Z; Rodriguez M; Zheng Z
Arterioscler Thromb Vasc Biol; 2024 Mar; 44(3):533-544. PubMed ID: 38235555
[TBL] [Abstract][Full Text] [Related]
10. A Case of Oral-contraceptive Related Ischemic Colitis in Young Woman.
Seon CS; Park YS; Park SH; Ryu SR; Jo YJ; Kim SH; Son BK; Ahn SB
Clin Endosc; 2011 Dec; 44(2):129-32. PubMed ID: 22741124
[TBL] [Abstract][Full Text] [Related]
11. Coupled Model of Blood Volume and Activated Clotting Factor Concentration during Childbirth.
Pressly MA; Neal MD; Waters JH; Clermont G; Parker RS
IFAC Pap OnLine; 2018; 51(19):52-55. PubMed ID: 33598665
[TBL] [Abstract][Full Text] [Related]
12. Genotyping oral contraceptive users for venous thromboembolism risk.
Lo Faro V; Johansson Å
Am J Obstet Gynecol; 2024 May; ():. PubMed ID: 38697340
[No Abstract] [Full Text] [Related]
13. Thromboembolic risk with gender-affirming hormone therapy: potential role of global coagulation and fibrinolysis assays.
Bouck EG; Grinsztejn E; Mcnamara M; Stavrou EX; Wolberg AS
Res Pract Thromb Haemost; 2023 Aug; 7(6):102197. PubMed ID: 37822706
[TBL] [Abstract][Full Text] [Related]
14. High risk oral contraceptive hormones do not directly enhance endothelial cell procoagulant activity in vitro.
Bouck EG; Arvanitis M; Osburn WO; Sang Y; Reventun P; Ahmadzia HK; Smith NL; Lowenstein CJ; Wolberg AS
PLoS One; 2023; 18(4):e0284333. PubMed ID: 37075041
[TBL] [Abstract][Full Text] [Related]
15. Oral Janus kinase inhibitors and venous thromboembolic events in atopic dermatitis: protocols for a case-time control study and a nested case-control study based on the French national health insurance (SNDS) cohort.
Berthe P; Scailteux LM; Lescoat A; Staumont D; Coiffier G; Guéret P; Dupuy A; Oger E; Droitcourt C
BMJ Open; 2022 Sep; 12(9):e059979. PubMed ID: 36130766
[TBL] [Abstract][Full Text] [Related]
16. Studies on oral contraceptive-induced changes in blood coagulation and fibrinolysis and the estrogen effect on endothelial cells.
Quehenberger P; Kapiotis S; Pärtan C; Schneider B; Wenzel R; Gaiger A; Speiser W
Ann Hematol; 1993 Jul; 67(1):33-6. PubMed ID: 8392873
[TBL] [Abstract][Full Text] [Related]
17. Clinical aspects of the relationship between oral contraceptives and abnormalities of the hemostatic system: relation to the development of cardiovascular disease.
Kelleher CC
Am J Obstet Gynecol; 1990 Jul; 163(1 Pt 2):392-5. PubMed ID: 2196811
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
